[{"NetIncomeLoss_1_Q1_USD":-64284000.0,"EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_0_Q1_USD":59329000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":14673000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":178000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":584000.0,"AssetsCurrent_0_Q1_USD":273771000.0,"OperatingLeaseExpense_1_Q1_USD":452000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":22114000.0,"FinanceLeaseLiabilityNoncurrent_0_Q1_USD":3883000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":182000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":5923000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":2177000.0,"InventoryValuationReserves_0_Q1_USD":270000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":666000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":14771000.0,"CommonStockSharesIssued_0_Q1_shares":177670000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":13454000.0,"Assets_0_Q1_USD":284431000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":179000.0,"ShareBasedCompensation_1_Q1_USD":5479000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":23741.0,"InventoryFinishedGoods_0_Q1_USD":270000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":32719000.0,"PaidInKindInterest_1_Q1_USD":3549000.0,"GainLossOnForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstruments_1_Q1_USD":-29000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":902000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":42435000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":10866000.0,"InventoryRawMaterials_0_Q1_USD":101000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":177343000.0,"AccountsReceivableNetCurrent_0_Q1_USD":18386000.0,"CommonStockValue_0_Q1_USD":1777000.0,"InterestPayableCurrent_0_Q1_USD":23547000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":178000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":2900000.0,"CostsAndExpenses_1_Q1_USD":70436000.0,"IncreaseDecreaseInInventories_1_Q1_USD":-1927000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-64105000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-7373000.0,"OtherAssetsNoncurrent_0_Q1_USD":3625000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":226902000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q1_USD":1000.0,"IncreaseDecreaseInReceivables_1_Q1_USD":261000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"InventoryGross_0_Q1_USD":5383000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":5982000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":582000.0,"PaymentsToAcquireProductiveAssets_1_Q1_USD":99000.0,"IncreaseDecreaseInDerivativeAssets_1_Q1_USD":0.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":805000.0,"LiabilitiesCurrent_0_Q1_USD":101201000.0,"DeferredRevenueCurrent_0_Q1_USD":405000.0,"AccountsPayableCurrent_0_Q1_USD":13529000.0,"InterestExpense_1_Q1_USD":12904000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":5908000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":2900000.0,"LongTermDebtNoncurrent_0_Q1_USD":123039000.0,"InterestExpenseDebt_1_Q1_USD":12904000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.128,"AdditionalPaidInCapital_0_Q1_USD":1010779000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":230910000.0,"AdvertisingExpense_1_Q1_USD":1404000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":593000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":723000.0,"OperatingLeasePayments_1_Q1_USD":440000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"ReceivablesNetCurrent_0_Q1_USD":8504000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":7035000.0,"InventoryWorkInProcess_0_Q1_USD":5012000.0,"IncreaseDecreaseInContractWithCustomerLiability_1_Q1_USD":255000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-61011000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":5479000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":9850000.0,"CommonStockSharesAuthorized_0_Q1_shares":450000000.0,"OperatingIncomeLoss_1_Q1_USD":-51377000.0,"NotesPayableCurrent_0_Q1_USD":30000000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":13454000.0,"InventoryNet_0_Q1_USD":5113000.0,"IncreaseDecreaseInInterestPayableNet_1_Q1_USD":1877000.0,"PreferredStockValue_0_Q1_USD":0.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":284431000.0,"PreferredStockSharesAuthorized_0_Q1_shares":5000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":5479000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q1_USD":4008000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.36,"FinanceLeaseLiabilityCurrent_0_Q1_USD":1001000.0,"StockholdersEquity_0_Q1_USD":-74988000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":13433000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":19059000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-1087726000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-43438000.0,"CommonStockSharesOutstanding_0_Q1_shares":177670000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":4000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodBeforeTax_1_Q1_USD":1000.0,"StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_1_Q1_shares":193000.0,"Ticker":"BCRX","CIK":"882796","name":"BIOCRYST PHARMACEUTICALS INC","OfficialName":"BioCryst Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1887243586.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20210507"}]